Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

34.15 -1.30 (-3.67%)
Streaming Delayed Price Updated: 2:32 PM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
News headline image
Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026? ↗
One prioritizes rapid consumer growth and profitability; the other commands scale but faces concentration risk. 
Via The Motley Fool
News headline image
As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner ↗
Hims & Hers Health shares have surged 45% in 30 days on GLP-1 coverage shifts, but overbought technicals, a Hold rating, and rising short interest suggest a pullback may be near. 
Via MarketBeat
News headline image
Here’s How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years ↗
Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 17.4% on an annualized basis producing an average annual return of 28.89%. Currently, Hims & Hers Health has a... 
Via Benzinga
News headline image
Hims & Hers Stock Surges as Analysts Lift Price Targets ↗
Hims & Hers Health Inc (NYSE:HIMS) shares are rising on Wenesday after B of A Securities and Canaccord Genuity raised their respective price targets on the stock. 
Via Benzinga
News headline image
Here's How Much $100 Invested In Hims & Hers Health 5 Years Ago Would Be Worth Today ↗
Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 14.14% on an annualized basis producing an average annual return of 25.67%. Currently, Hims & Hers Health has a... 
Via Benzinga
News headline image
2 Unpopular Stocks That Deserve a Second Chance and 1 We Question
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord... 
Via StockStory
News headline image
1 Surging Stock Worth Your Attention and 2 We Find Risky
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne... 
Via StockStory
Topics Supply Chain
News headline image
Hims & Hers Stock Jumps After Barclays Raises Price Target ↗
Hims & Hers Health (NYSE: HIMS) shares are climbing after Barclays reiterated its bullish stance and lifted its price target from $29 to $39. 
Via Benzinga
News headline image
Hims & Hers Stock Is Climbing Tuesday: What Investors Need To Know ↗
Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher on Tuesday as the stock continues to rebound from recent profit-taking. 
Via Benzinga
News headline image
3 Market-Beating Stocks with Exciting Potential
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three ... 
Via StockStory
News headline image
Great News: Wall Street Is Turning Bullish on This Troubled Telehealth Stock ↗
This telehealth stock has fallen hard, but its GLP-1 shift and global expansion could reshape the long-term story. Is the market too skeptical or still too optimistic? 
Via The Motley Fool
News headline image
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims
From Hims & Hers
Via Business Wire
News headline image
1 Growth Stock Set to Flourishand 2 We Ignore
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil... 
Via StockStory
Topics Economy
News headline image
Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform
From Hims & Hers
Via Business Wire
News headline image
2 Unprofitable Stocks with Competitive Advantages and 1 Facing Headwinds
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th... 
Via StockStory
News headline image
Is Hims & Hers Stock an Undervalued Stock to Buy? ↗
The healthcare industry is ripe for disruption. 
Via The Motley Fool
News headline image
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders? ↗
Hims & Hers is acquiring Australian telehealth platform Eucalyptus as part of its international expansion plan while using $350 million in convertible senior notes. 
Via MarketBeat
Topics Earnings
News headline image
Hims & Hers Shares Rally On Million-Dollar Insider Purchase ↗
Shares of Hims & Hers Health Inc (NYSE: HIMS) are trading higher Wednesday morning after insider stock purchase boosts investor confidence. 
Via Benzinga
News headline image
The Silver Lining of Last Week's Hims & Hers Earnings Miss ↗
Hims & Hers plunged 23% after a major Q1 earnings miss, but long-term growth stays intact via its Novo Nordisk GLP-1 partnership and a late 2026 expansion. 
Via MarketBeat
Topics Earnings
News headline image
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:MMA),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Government
News headline image
Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide
From Hims & Hers
Via Business Wire
News headline image
Peptide-Based Health Industry Positioned for Explosive Long-Term Growth Across Global Wellness Markets
Analysts project billions in future market value as biotech innovation and consumer demand continue driving the next wave of health performance products 
From MarketNewsUpdates.com
Via GlobeNewswire
News headline image
Hims & Hers Massive Stock Drop Explained ↗
Raising debt increases the risk in Hims & Hers' stock. 
Via The Motley Fool
News headline image
Hims & Hers Stock Stabilizes After Upsized $350 Million Convertible Note Offering ↗
Hims & Hers Health (NYSE: HIMS) shares are trading flat in Tuesday's pre-market as traders continue to digest its convertible notes offering. 
Via Benzinga
News headline image
Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment
From Hims & Hers
Via Business Wire
News headline image
5 Revealing Analyst Questions From Hims & Hers Health’s Q1 Earnings Call
Hims & Hers Health’s first quarter was marked by a significant strategic pivot in its weight loss business, which management described as a move to prioritiz... 
Via StockStory
Topics Earnings Economy
News headline image
Spotting Winners: Hims & Hers Health (NYSE:HIMS) And Healthcare Technology Stocks In Q1
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including Hims & Hers Health (NYSE:HIMS) and its peer... 
Via StockStory
News headline image
Hims & Hers Stock Drops After Earnings: Buying Opportunity or Warning Sign? ↗
Hims & Hers continues growing rapidly, but shrinking margins and rising costs are beginning to test the company's long-term profitability story. 
Via The Motley Fool
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.